ACADS and neoplasm: Secondly, the analysis of all other biomarkers identified in Section 2.2, Section 2.3 and Section 2.4 and illustrated in Figure 2, Figure 3, Figure 4 and Figure 5 showed that, as for trypsinogens, abundance decrease and increase were enhanced with tumor progression for three (ACADS, CHSP1, SARDH) and 16 additional proteins (ADHX, AL1L1, CO5A1, CP2B1, DNJC8, DX39A, FETUA, FIBG, GRPE1, IRGM, MMGT1, PDLI1, PELP1, PGRC1, RTCB, S10A6), respectively.